7th Dec 2012 18:07
Notification of Transactions of (1) Persons Discharging Managerial Responsibility and (2) Persons closely associated with Persons Discharging Managerial Responsibility
This form is intended for use by an issuer making a notification required by Rules 7.2 and 7.3 of the Central Bank of Ireland's Market Abuse Rules in relation to a person falling within either of the above categories of individual. These categories are defined in Regulation 12 (8) of the Market Abuse (Directive 2003/6/EC) Regulations 2005 and are detailed as part of this form.
All relevant boxes should be completed in block capital letters.
1 | Name of the Issuer
UNITED DRUG PLC
| 2 | Name of person discharging managerial responsibilities
MR. CHRIS CORBIN
|
3 | State whether notification relates to a person closely associated with a person discharging managerial responsibilities named in 2 and identify the connected person
N/A | 4 | Indicate whether the notification is in respect of a holding of the person referred to in 2 or 3 above or in respect of a non-beneficial interest
RELATES TO PERSON NAMED IN 2
|
5 | Description of shares or derivatives or other financial instruments linked to them
ORDINARY SHARES OF €0.05 EACH | 6 | Name of registered shareholder(s) and, if more than one, number of shares or derivatives or other financial instruments linked to them, held by each shareholder
N\A |
7 | State the nature of the transaction
GRANTING OF SHARE OPTIONS
| 8 | Number of shares, derivatives or other financial instruments linked to them acquired
N\A
|
9 | Number of shares, derivatives or other financial instruments linked to them disposed of
N\A | 10 | Price per share or derivative or other financial instrument linked to them or value of transaction
N\A
|
11 | Date and place of transaction
7 DECEMBER 2012 | 12 | Date issuer informed of transaction
7 DECEMBER 2012 |
13 | Any additional information
SHARE OPTIONS WILL BE ENTITLED TO DIVIDEND EQUIVALENTS | 14 | Name of contact and telephone number for queries
KAREN GEOGHEGAN + 353 1 463 7720 |
Name and signature of duly designated officer of issuer responsible for making notification
Karen Geoghegan__________________
Date of notification 7 December 2012_ | |||
The following additional information is also disclosed by the issuer.
The issuer is not required to submit the following information to the Central Bank of Ireland.
15 | Description of class of share
N\A
| 16 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
N\A
|
17 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
N\A
| 18 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)
N\A
|
If a person discharging managerial responsibilities has been granted options by the issuer, please complete the following boxes:
19 | Date of grant
7 DECEMBER 2012
| 20 | Period during which or date on which it can be exercised
7 DECEMBER 2015 to 6 DECEMBER 2019
|
21 | Total amount paid (if any) for grant of the option
N/A
| 22 | Description of shares involved (class and number)
107,462 NOMINAL VALUE SHARE OPTIONS OVER ORDINARY SHARES
|
23 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise
€0.05
| 24 | Total number of shares over which options are held following notification
981,411
|
Notification of Transactions of (1) Persons Discharging Managerial Responsibility and (2) Persons closely associated with Persons Discharging Managerial Responsibility
This form is intended for use by an issuer making a notification required by Rules 7.2 and 7.3 of the Central Bank of Ireland's Market Abuse Rules in relation to a person falling within either of the above categories of individual. These categories are defined in Regulation 12 (8) of the Market Abuse (Directive 2003/6/EC) Regulations 2005 and are detailed as part of this form.
All relevant boxes should be completed in block capital letters.
1 | Name of the Issuer
UNITED DRUG PLC
| 2 | Name of person discharging managerial responsibilities
MR. LIAM FITZGERALD
|
3 | State whether notification relates to a person closely associated with a person discharging managerial responsibilities named in 2 and identify the connected person
N/A | 4 | Indicate whether the notification is in respect of a holding of the person referred to in 2 or 3 above or in respect of a non-beneficial interest
RELATES TO PERSON NAMED IN 2
|
5 | Description of shares or derivatives or other financial instruments linked to them
ORDINARY SHARES OF €0.05 EACH | 6 | Name of registered shareholder(s) and, if more than one, number of shares or derivatives or other financial instruments linked to them, held by each shareholder
N\A |
7 | State the nature of the transaction
GRANTING OF SHARE OPTIONS
| 8 | Number of shares, derivatives or other financial instruments linked to them acquired
N\A
|
9 | Number of shares, derivatives or other financial instruments linked to them disposed of
N\A | 10 | Price per share or derivative or other financial instrument linked to them or value of transaction
N\A
|
11 | Date and place of transaction
7 DECEMBER 2012 | 12 | Date issuer informed of transaction
7 DECEMBER 2012 |
13 | Any additional information
SHARE OPTIONS WILL BE ENTITLED TO DIVIDEND EQUIVALENTS | 14 | Name of contact and telephone number for queries
KAREN GEOGHEGAN + 353 1 463 7720 |
Name and signature of duly designated officer of issuer responsible for making notification
Karen Geoghegan__________________
Date of notification 7 December 2012_ | |||
The following additional information is also disclosed by the issuer.
The issuer is not required to submit the following information to the Central Bank of Ireland.
15 | Description of class of share
N\A
| 16 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
N\A
|
17 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
N\A
| 18 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)
N\A
|
If a person discharging managerial responsibilities has been granted options by the issuer, please complete the following boxes:
19 | Date of grant
7 DECEMBER 2012
| 20 | Period during which or date on which it can be exercised
7 DECEMBER 2015 to 6 DECEMBER 2019
|
21 | Total amount paid (if any) for grant of the option
N/A
| 22 | Description of shares involved (class and number)
172,563 NOMINAL VALUE SHARE OPTIONS OVER ORDINARY SHARES
|
23 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise
€0.05
| 24 | Total number of shares over which options are held following notification
1,419,976
|
Notification of Transactions of (1) Persons Discharging Managerial Responsibility and (2) Persons closely associated with Persons Discharging Managerial Responsibility
This form is intended for use by an issuer making a notification required by Rules 7.2 and 7.3 of the Central Bank of Ireland's Market Abuse Rules in relation to a person falling within either of the above categories of individual. These categories are defined in Regulation 12 (8) of the Market Abuse (Directive 2003/6/EC) Regulations 2005 and are detailed as part of this form.
All relevant boxes should be completed in block capital letters.
1 | Name of the Issuer
UNITED DRUG PLC
| 2 | Name of person discharging managerial responsibilities
MR. MIKE GANNON
|
3 | State whether notification relates to a person closely associated with a person discharging managerial responsibilities named in 2 and identify the connected person
N/A | 4 | Indicate whether the notification is in respect of a holding of the person referred to in 2 or 3 above or in respect of a non-beneficial interest
RELATES TO PERSON NAMED IN 2
|
5 | Description of shares or derivatives or other financial instruments linked to them
ORDINARY SHARES OF €0.05 EACH | 6 | Name of registered shareholder(s) and, if more than one, number of shares or derivatives or other financial instruments linked to them, held by each shareholder
N\A |
7 | State the nature of the transaction
GRANTING OF SHARE OPTIONS
| 8 | Number of shares, derivatives or other financial instruments linked to them acquired
N\A
|
9 | Number of shares, derivatives or other financial instruments linked to them disposed of
N\A | 10 | Price per share or derivative or other financial instrument linked to them or value of transaction
N\A
|
11 | Date and place of transaction
7 DECEMBER 2012 | 12 | Date issuer informed of transaction
7 DECEMBER 2012 |
13 | Any additional information
SHARE OPTIONS WILL BE ENTITLED TO DIVIDEND EQUIVALENTS | 14 | Name of contact and telephone number for queries
KAREN GEOGHEGAN + 353 1 463 7720 |
Name and signature of duly designated officer of issuer responsible for making notification
Karen Geoghegan__________________
Date of notification 7 December 2012_ | |||
The following additional information is also disclosed by the issuer.
The issuer is not required to submit the following information to the Central Bank of Ireland.
15 | Description of class of share
N\A
| 16 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
N\A
|
17 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
N\A
| 18 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)
N\A
|
If a person discharging managerial responsibilities has been granted options by the issuer, please complete the following boxes:
19 | Date of grant
7 DECEMBER 2012
| 20 | Period during which or date on which it can be exercised
7 DECEMBER 2015 to 6 DECEMBER 2019
|
21 | Total amount paid (if any) for grant of the option
N/A
| 22 | Description of shares involved (class and number)
31,311 NOMINAL VALUE SHARE OPTIONS OVER ORDINARY SHARES
|
23 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise
€0.05
| 24 | Total number of shares over which options are held following notification
202,344
|
Notification of Transactions of (1) Persons Discharging Managerial Responsibility and (2) Persons closely associated with Persons Discharging Managerial Responsibility
This form is intended for use by an issuer making a notification required by Rules 7.2 and 7.3 of the Central Bank of Ireland's Market Abuse Rules in relation to a person falling within either of the above categories of individual. These categories are defined in Regulation 12 (8) of the Market Abuse (Directive 2003/6/EC) Regulations 2005 and are detailed as part of this form.
All relevant boxes should be completed in block capital letters.
1 | Name of the Issuer
UNITED DRUG PLC
| 2 | Name of person discharging managerial responsibilities
MR. LIAM LOGUE
|
3 | State whether notification relates to a person closely associated with a person discharging managerial responsibilities named in 2 and identify the connected person
N/A | 4 | Indicate whether the notification is in respect of a holding of the person referred to in 2 or 3 above or in respect of a non-beneficial interest
RELATES TO PERSON NAMED IN 2
|
5 | Description of shares or derivatives or other financial instruments linked to them
ORDINARY SHARES OF €0.05 EACH | 6 | Name of registered shareholder(s) and, if more than one, number of shares or derivatives or other financial instruments linked to them, held by each shareholder
N\A |
7 | State the nature of the transaction
GRANTING OF SHARE OPTIONS
| 8 | Number of shares, derivatives or other financial instruments linked to them acquired
N\A
|
9 | Number of shares, derivatives or other financial instruments linked to them disposed of
N\A | 10 | Price per share or derivative or other financial instrument linked to them or value of transaction
N\A
|
11 | Date and place of transaction
7 DECEMBER 2012 | 12 | Date issuer informed of transaction
7 DECEMBER 2012 |
13 | Any additional information
SHARE OPTIONS WILL BE ENTITLED TO DIVIDEND EQUIVALENTS | 14 | Name of contact and telephone number for queries
KAREN GEOGHEGAN + 353 1 463 7720 |
Name and signature of duly designated officer of issuer responsible for making notification
Karen Geoghegan__________________
Date of notification 7 December 2012_ | |||
The following additional information is also disclosed by the issuer.
The issuer is not required to submit the following information to the Central Bank of Ireland.
15 | Description of class of share
N\A
| 16 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
N\A
|
17 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
N\A
| 18 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)
N\A
|
If a person discharging managerial responsibilities has been granted options by the issuer, please complete the following boxes:
19 | Date of grant
7 DECEMBER 2012
| 20 | Period during which or date on which it can be exercised
7 DECEMBER 2015 to 6 DECEMBER 2019
|
21 | Total amount paid (if any) for grant of the option
N/A
| 22 | Description of shares involved (class and number)
31,787 NOMINAL VALUE SHARE OPTIONS OVER ORDINARY SHARES
|
23 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise
€0.05
| 24 | Total number of shares over which options are held following notification
464,185
|
Notification of Transactions of (1) Persons Discharging Managerial Responsibility and (2) Persons closely associated with Persons Discharging Managerial Responsibility
This form is intended for use by an issuer making a notification required by Rules 7.2 and 7.3 of the Central Bank of Ireland's Market Abuse Rules in relation to a person falling within either of the above categories of individual. These categories are defined in Regulation 12 (8) of the Market Abuse (Directive 2003/6/EC) Regulations 2005 and are detailed as part of this form.
All relevant boxes should be completed in block capital letters.
1 | Name of the Issuer
UNITED DRUG PLC
| 2 | Name of person discharging managerial responsibilities
MR. ALAN RALPH
|
3 | State whether notification relates to a person closely associated with a person discharging managerial responsibilities named in 2 and identify the connected person
N/A | 4 | Indicate whether the notification is in respect of a holding of the person referred to in 2 or 3 above or in respect of a non-beneficial interest
RELATES TO PERSON NAMED IN 2
|
5 | Description of shares or derivatives or other financial instruments linked to them
ORDINARY SHARES OF €0.05 EACH | 6 | Name of registered shareholder(s) and, if more than one, number of shares or derivatives or other financial instruments linked to them, held by each shareholder
N\A |
7 | State the nature of the transaction
GRANTING OF SHARE OPTIONS
| 8 | Number of shares, derivatives or other financial instruments linked to them acquired
N\A
|
9 | Number of shares, derivatives or other financial instruments linked to them disposed of
N\A | 10 | Price per share or derivative or other financial instrument linked to them or value of transaction
N\A
|
11 | Date and place of transaction
7 DECEMBER 2012 | 12 | Date issuer informed of transaction
7 DECEMBER 2012 |
13 | Any additional information
SHARE OPTIONS WILL BE ENTITLED TO DIVIDEND EQUIVALENTS | 14 | Name of contact and telephone number for queries
KAREN GEOGHEGAN + 353 1 463 7720 |
Name and signature of duly designated officer of issuer responsible for making notification
Karen Geoghegan__________________
Date of notification 7 December 2012_ | |||
The following additional information is also disclosed by the issuer.
The issuer is not required to submit the following information to the Central Bank of Ireland.
15 | Description of class of share
N\A
| 16 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
N\A
|
17 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
N\A
| 18 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)
N\A
|
If a person discharging managerial responsibilities has been granted options by the issuer, please complete the following boxes:
19 | Date of grant
7 DECEMBER 2012
| 20 | Period during which or date on which it can be exercised
7 DECEMBER 2015 to 6 DECEMBER 2019
|
21 | Total amount paid (if any) for grant of the option
N/A
| 22 | Description of shares involved (class and number)
100,661 NOMINAL VALUE SHARE OPTIONS OVER ORDINARY SHARES
|
23 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise
€0.05
| 24 | Total number of shares over which options are held following notification
744,209
|
Notification of Transactions of (1) Persons Discharging Managerial Responsibility and (2) Persons closely associated with Persons Discharging Managerial Responsibility
This form is intended for use by an issuer making a notification required by Rules 7.2 and 7.3 of the Central Bank of Ireland's Market Abuse Rules in relation to a person falling within either of the above categories of individual. These categories are defined in Regulation 12 (8) of the Market Abuse (Directive 2003/6/EC) Regulations 2005 and are detailed as part of this form.
All relevant boxes should be completed in block capital letters.
1 | Name of the Issuer
UNITED DRUG PLC
| 2 | Name of person discharging managerial responsibilities
MR. ENDA SCOTT
|
3 | State whether notification relates to a person closely associated with a person discharging managerial responsibilities named in 2 and identify the connected person
N/A | 4 | Indicate whether the notification is in respect of a holding of the person referred to in 2 or 3 above or in respect of a non-beneficial interest
RELATES TO PERSON NAMED IN 2
|
5 | Description of shares or derivatives or other financial instruments linked to them
ORDINARY SHARES OF €0.05 EACH | 6 | Name of registered shareholder(s) and, if more than one, number of shares or derivatives or other financial instruments linked to them, held by each shareholder
N\A |
7 | State the nature of the transaction
GRANTING OF SHARE OPTIONS
| 8 | Number of shares, derivatives or other financial instruments linked to them acquired
N\A
|
9 | Number of shares, derivatives or other financial instruments linked to them disposed of
N\A | 10 | Price per share or derivative or other financial instrument linked to them or value of transaction
N\A
|
11 | Date and place of transaction
7 DECEMBER 2012 | 12 | Date issuer informed of transaction
7 DECEMBER 2012 |
13 | Any additional information
SHARE OPTIONS WILL BE ENTITLED TO DIVIDEND EQUIVALENTS | 14 | Name of contact and telephone number for queries
KAREN GEOGHEGAN + 353 1 463 7720 |
Name and signature of duly designated officer of issuer responsible for making notification
Karen Geoghegan__________________
Date of notification 7 December 2012_ | |||
The following additional information is also disclosed by the issuer.
The issuer is not required to submit the following information to the Central Bank of Ireland.
15 | Description of class of share
N\A
| 16 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
N\A
|
17 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
N\A
| 18 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)
N\A
|
If a person discharging managerial responsibilities has been granted options by the issuer, please complete the following boxes:
19 | Date of grant
7 DECEMBER 2012
| 20 | Period during which or date on which it can be exercised
7 DECEMBER 2015 to 6 DECEMBER 2019
|
21 | Total amount paid (if any) for grant of the option
N/A
| 22 | Description of shares involved (class and number)
62,062 NOMINAL VALUE SHARE OPTIONS OVER ORDINARY SHARES
|
23 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise
€0.05
| 24 | Total number of shares over which options are held following notification
106,627
|
Notification of Transactions of (1) Persons Discharging Managerial Responsibility and (2) Persons closely associated with Persons Discharging Managerial Responsibility
This form is intended for use by an issuer making a notification required by Rules 7.2 and 7.3 of the Central Bank of Ireland's Market Abuse Rules in relation to a person falling within either of the above categories of individual. These categories are defined in Regulation 12 (8) of the Market Abuse (Directive 2003/6/EC) Regulations 2005 and are detailed as part of this form.
All relevant boxes should be completed in block capital letters.
1 | Name of the Issuer
UNITED DRUG PLC
| 2 | Name of person discharging managerial responsibilities
MS. KAREN GEOGHEGAN
|
3 | State whether notification relates to a person closely associated with a person discharging managerial responsibilities named in 2 and identify the connected person
N/A | 4 | Indicate whether the notification is in respect of a holding of the person referred to in 2 or 3 above or in respect of a non-beneficial interest
RELATES TO PERSON NAMED IN 2
|
5 | Description of shares or derivatives or other financial instruments linked to them
ORDINARY SHARES OF €0.05 EACH | 6 | Name of registered shareholder(s) and, if more than one, number of shares or derivatives or other financial instruments linked to them, held by each shareholder
N\A |
7 | State the nature of the transaction
GRANTING OF SHARE OPTIONS
| 8 | Number of shares, derivatives or other financial instruments linked to them acquired
N\A
|
9 | Number of shares, derivatives or other financial instruments linked to them disposed of
N\A | 10 | Price per share or derivative or other financial instrument linked to them or value of transaction
N\A
|
11 | Date and place of transaction
7 DECEMBER 2012 | 12 | Date issuer informed of transaction
7 DECEMBER 2012 |
13 | Any additional information
N\A | 14 | Name of contact and telephone number for queries
KAREN GEOGHEGAN + 353 1 463 7720 |
Name and signature of duly designated officer of issuer responsible for making notification
Karen Geoghegan__________________
Date of notification 7 December 2012_ | |||
The following additional information is also disclosed by the issuer.
The issuer is not required to submit the following information to the Central Bank of Ireland.
15 | Description of class of share
N\A
| 16 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
N\A
|
17 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
N\A
| 18 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)
N\A
|
If a person discharging managerial responsibilities has been granted options by the issuer, please complete the following boxes:
19 | Date of grant
7 DECEMBER 2012
| 20 | Period during which or date on which it can be exercised
7 DECEMBER 2015 to 6 DECEMBER 2019
|
21 | Total amount paid (if any) for grant of the option
N/A
| 22 | Description of shares involved (class and number)
30,200 SHARE OPTIONS OVER ORDINARY SHARES
|
23 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise
£2.68
| 24 | Total number of shares over which options are held following notification
125,200
|
Related Shares:
UDG.L